8-K: BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates
15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
8-K: Current report
8-K: Current report
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
8-K: Current report
S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
8-K: Current report
DEF 14A: Definitive information statements
8-K/A: Current report (Amendment)
8-K: Current report
PRE 14A: Preliminary proxy statements relating to merger or acquisition
NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
S-3: Registration statement for specified transactions by certain issuers
BIOMX INC C/WTS 16/10/2024 (TO PUR COM) | 8-K: Current report
BIOMX INC C/WTS 16/10/2024 (TO PUR COM) | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
BIOMX INC C/WTS 16/10/2024 (TO PUR COM) | 8-K: BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
BIOMX INC C/WTS 16/10/2024 (TO PUR COM) | NT 10-K: Others
No Data
No Data